Cite
APA Citation
Brunton, S., Rozjabek, H. M., Pilon, D., Lafeuille, M., Kamstra, R., Wynant, W., Bookhart, B. K., & Lefebvre, P. (2019). real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a sodium glucose co-transporter 2 (SGLT2) inhibitor (SGLT2i). Current medical research and opinion, 35, 1607–1614. http://access.bl.uk/ark:/81055/vdc_100089547526.0x000049